Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response

Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response

Abstract Objectives Assessment of the adaptive immune response against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is crucial for studying long‐term immunity and vaccine strategies. We quantified IFNγ‐secreting T cells reactive against the main viral SARS‐CoV‐2 antigens using a stan...

Full description

Bibliographic Details
Main Authors: Julie Demaret, Guillaume Lefèvre, Fanny Vuotto, Jacques Trauet, Alain Duhamel, Julien Labreuche, Pauline Varlet, Arnaud Dendooven, Sarah Stabler, Benoit Gachet, Jules Bauer, Brigitte Prevost, Laurence Bocket, Enagnon Kazali Alidjinou, Marc Lambert, Cécile Yelnik, Bertrand Meresse, Laurent Dubuquoy, David Launay, Sylvain Dubucquoi, David Montaigne, Eloise Woitrain, François Maggiotto, Mohamed Bou Saleh, Isabelle Top, Vincent Elsermans, Emmanuelle Jeanpierre, Annabelle Dupont, Sophie Susen, Thierry Brousseau, Julien Poissy, Karine Faure, Myriam Labalette, the Lille Covid Research Network (LICORNE)
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Clinical & Translational Immunology
Subjects:
ELISpot
SARS‐CoV‐2
T cells
Online Access:https://doi.org/10.1002/cti2.1217

Internet

https://doi.org/10.1002/cti2.1217

Similar Items